Whitehawk Therapeutics Inc

NASDAQ:WHWK

Biotechnology

Healthcare
$3.12 +1.42%

+$0.06 today

Market cap
$184.11M
Beta
0.77
P/E (TTM)
-2.6
EPS (TTM)
-$1.67
52W Low $1.57High $5.50

Volume 0.40M

Average 0.31M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$97.43M

FY 2025 · Annual

Investing Cash Flow

$11.89M

FY 2025 · Annual

-52.8% YoY

Financing Cash Flow

$94.38M

FY 2025 · Annual

+72496.9% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(110.09M)(60.51M)(65.77M)(63.69M)(20.6M)
Depreciation & Amortization105K159K169K193K79K
Deferred Income Tax00000
Stock-Based Compensation2.11M9.64M11.95M10.84M9.87M
Change in Working Capital3.96M(5.04M)(3.27M)3.72M1.93M
Accounts Receivables14.15M(1.86M)(3.63M)(415K)(1M)
Inventory0(1.86M)(3.27M)1.12M170K
Accounts Payables00003.92M
Other Working Capital(10.19M)(1.32M)3.62M3.02M(1.16M)
Other Non-Cash Items81.5M6.11M(2.75M)(10.61M)(78.77M)
Operating Cash Flow(22.42M)(49.64M)(59.66M)(59.55M)(97.43M)
Capital Expenditures(46K)(444K)(3.97M)(1.65M)(552K)
Acquisitions (Net)25.2M000101.29M
Purchases of Investments0(145.19M)(64.44M)(36.48M)(148.69M)
Sales of Investments012.75M151.62M63.34M59.85M
Other Investing Activities00000
Investing Cash Flow25.15M(132.89M)83.21M25.2M11.89M
Debt Repayment00000
Common Stock Issued155M72.5M0130K100M
Common Stock Repurchased00000
Dividends Paid(4.41M)0000
Other Financing Activities(8.78M)120K326K(16K)(5.63M)
Financing Cash Flow141.8M72.62M326K130K94.38M
Effect of Forex Changes000064K
Net Change in Cash144.53M(109.91M)23.87M(34.22M)8.9M
Free Cash Flow(22.47M)(50.08M)(63.64M)(61.2M)(97.99M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$20.6M
+ D&A$79.0K
+ Stock-Based Comp$9.9M
+ Deferred Tax$0
+ Working Capital$1.9M
- Other Non-Cash-$78.8M
= Operating Cash Flow-$97.4M
- Capex-$552.0K
= Free Cash Flow-$98.0M

Analysis

FY2025 free cash flow is -$98.0M. FCF conversion is 475.7% of net income. Operating cash flow was -$97.4M, with capex of -$552.0K. The largest bridge item is Other Non-Cash at -$78.8M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
DEFA14ADEFA14A filingApr 28, 2026
ARSARS filingApr 28, 2026

Does WHWK generate free cash flow?

Whitehawk Therapeutics Inc (WHWK) generated -$97.98M of free cash flow in fiscal 2025.

How much operating cash flow does WHWK produce?

Operating cash flow was -$97.43M, before capital expenditures of $552,000.00.